financetom
Business
financetom
/
Business
/
Qualcomm Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Q2 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Qualcomm Fiscal Q1 Non-GAAP Earnings, Revenue Rise; Q2 Outlook Set
Feb 5, 2025 1:29 PM

04:11 PM EST, 02/05/2025 (MT Newswires) -- Qualcomm ( QCOM ) reported fiscal Q1 non-GAAP earnings late Wednesday of $3.41 per diluted share, up from $2.75 a year earlier.

Analysts polled by FactSet expected $2.96.

Revenue in the three months ended Dec. 29 rose to $11.67 billion from $9.94 billion a year earlier.

Analysts surveyed by FactSet expected $10.91 billion.

The company expects fiscal Q2 non-GAAP EPS of $2.70 to $2.90 on revenue of $10.30 billion to $11.20 billion. Analysts surveyed by FactSet project EPS of $2.69 on revenue of $10.34 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KKR Unit Announces Offer to Buy Alps Logistics at $37.05 Per Share
KKR Unit Announces Offer to Buy Alps Logistics at $37.05 Per Share
May 9, 2024
08:06 AM EDT, 05/09/2024 (MT Newswires) -- KKR & Co ( KKR ) unit Logisteed announced a tender offer for Alps Logistics at 5,774 Japanese yen ($37.05) per share. Price: 99.99, Change: +0.32, Percent Change: +0.32 ...
Primo Water's Q1 Adjusted Earnings, Revenue Increase
Primo Water's Q1 Adjusted Earnings, Revenue Increase
May 9, 2024
08:06 AM EDT, 05/09/2024 (MT Newswires) -- Primo Water ( PRMW ) reported Q1 adjusted earnings Thursday of $0.19 per diluted share, up from $0.07 a year earlier. Analysts polled by Capital IQ expected $0.14. Revenue for the quarter ended March 30 was $452 million, compared with $412.5 million a year earlier. Analysts surveyed by Capital IQ expected $439 million....
Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer
Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer
May 9, 2024
08:08 AM EDT, 05/09/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, on Thursday said it will start enrollment for a new GOBLET study pancreatic cancer cohort after receiving German regulatory and ethics approvals. This cohort will evaluate Oncolytic's pelareorep in combination with modified folfirinox (mFOLFIRINOX) with or without the PD-L1...
Market Chatter: Whistleblower Claims Boeing Supplier Spirit AeroSystems Regularly Shipped Defective Fuselages
Market Chatter: Whistleblower Claims Boeing Supplier Spirit AeroSystems Regularly Shipped Defective Fuselages
May 9, 2024
08:09 AM EDT, 05/09/2024 (MT Newswires) -- Santiago Paredes, who worked for Spirit AeroSystems ( SPR ) , regularly found anywhere from 50 to 100, 200 defects on fuselages that were being shipped to Boeing ( BA ) , he told CBS News in an interview broadcast late Wednesday. (Market Chatter news is derived from conversations with market professionals globally....
Copyright 2023-2026 - www.financetom.com All Rights Reserved